It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China

Phase I

Phase I

Home / Services / Phase I

Dedicated state-of-the-art Phase-I units in Ahmedabad (India), Toronto (Canada) & Novum (USA) enable us to have a synergistic approach across geographies for timeline and cost advantages. Till date, Lambda has successfully executed over 43 phase-1 studies in the last 5 years for various formulations including Oral, Parenteral, Inhalers, Topical, Transdermal, Nasal Sprays, Injectables, Pessaries, Suppositories etc.

Lambda has strong technical expertise in handling studies like:

  • Single Ascending Dose (SAD) - First in Man
  • Multiple Ascending Dose (MAD)
  • BA/BE Bio comparison
  • Drug-Drug Interaction
  • Food-Drug Interaction
  • PK-PD
  • Proof-of-concept
  • Irritation, Sensitization, Adhesion
  • Cardiac Safety
  • Vasoconstrictor Studies for Topical Cortico steroids
  • Special Patient Populations
  • Potency Ranking Studies
  • Drug-Device Combinations
  • Food Effect  Studies

NCE Therapeutic Categories




Anti–inflammatory Agents



Antidementia Agents


Antimigraine Agents

Blood Glucose Regulators

Blood Modifiers

Cardiovascular Agents

Central Nervous System Agents

Dermatological Agents

Gastrointestinal Agents

Hormonal Agents

Immunological Agents

Ophthalmic Agents

Respiratory Agents



Inflammatory Bowel Diseases



Value Proposition


  • FiH Or SAD study in Canada & US
  • Faster regulatory approval
  • Parallel submission for MAD study in India
  • Study starts with healthy subjects followed by patient cohorts


  • Cost-effective option for subsequent Phase-1 studies
  • Easier Access for Renal and Liver impaired subjects study


  • Cost-effective business model (Hybrid)
  • Faster Turn Around Time
  • Global scientific overview
  • Flexible Operational approach

Looking for a Globally Proven Research Partner?

Contact Us